Bank of America’s Alder Biopharmaceuticals ALDR Stock Holding History

Bank of America’s Portfolio ALDR Stock Details ALDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-19,800	Closed	-$251K	–	7482
2018 Q1	$251K	Buy	+19,800	New	+$286K	﹤0.01%	5242
2016 Q4	–	Sell	-25,000	Closed	-$819K	–	7498
2016 Q3	$819K	Hold	25,000	–	–	﹤0.01%	4293
2016 Q2	$624K	Sell	25,000 -33,800	-57%	-$914K	﹤0.01%	4510
2016 Q1	$1.44M	Buy	+58,800	New	+$1.36M	﹤0.01%	3845

Bank of America's ALDR Position: Q4 2019 in Review

Bank of America sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 97,105 shares — an estimated $1.83M sold.

Bank of America first reported a position in ALDR in Q3 2014 and held it in 21 quarters. The position peaked at $8.41M in Q2 2018. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.

Bank of America reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
Bank of America sold 97,105 Alder Biopharmaceuticals shares in Q4 2019, an estimated $1.83M.
Bank of America first reported a position in Alder Biopharmaceuticals in Q3 2014 and held it in 21 quarters.
Bank of America's Alder Biopharmaceuticals position peaked at $8.41M in Q2 2018.
0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.

Based on Bank of America's 13F filing for Q4 2019, filed 14 Feb 2020.